Sudden death: ACE inhibitors and beta-blockers.

Abstract

Sudden death is extremely common in patients suffering from cardiovascular diseases. At least one third of those with hypertension and probably about half of those who survive a myocardial infarction or suffer from cardiac failure who die in a clinical trial, die suddenly. Beta-blockers reduce the risk of sudden death in patients with cardiovascular disease, particularly in those who have had a myocardial infarction or heart failure. ACE inhibitors are perhaps less effective. Other cardiovascular drugs have not been shown to reduce the risk of sudden death.

• Authors: M J Landray
• Journal: Basic research in cardiology (Basic Res Cardiol) Vol. 95 Suppl 1 Pg. I37-40 ( 2000) ISSN: 0300-8428 [Print] Germany
• PMID: 11192351 (Publication Type: Journal Article, Review)

Chemical References

• Adrenergic beta-Antagonists
• Angiotensin-Converting Enzyme Inhibitors

Topics

• Adrenergic beta-Antagonists (therapeutic use)
• Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
• Death, Sudden, Cardiac (prevention & control)
• Humans
• Hypertension (drug therapy)
• Myocardial Infarction (drug therapy)